Integra Therapeutics at ‘Pharmaceutical Technology’

Pharmaceutical Technology review publishes an article entitled Integra Therapeutics Q&A: building next-generation gene editing tools where our CEO Avencia Sánchez-Mejías discusses how the company’s gene writing tool could improve advanced therapies for patients. By Darcy Jimenez